SG/CALL/MERCK & CO./114/0.1/21.06.24 Share Price

Warrant

DE000SQ3S866

Delayed Deutsche Boerse AG 02:31:47 24/05/2024 pm IST
1.57 EUR -2.48% Intraday chart for SG/CALL/MERCK & CO./114/0.1/21.06.24
Current month+4.55%
1 month+16.67%
Date Price Change
24/24/24 1.57 -2.48%
23/24/23 1.61 -0.62%
22/24/22 1.62 +2.53%
21/24/21 1.58 -3.07%
20/24/20 1.63 +1.24%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 02:31 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ3S86
ISINDE000SQ3S866
Date issued 03/11/2022
Strike 114 $
Maturity 21/06/2024 (29 Days)
Parity 10 : 1
Emission price 0.94
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.85
Lowest since issue 0.23

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.1 USD
Average target price
141.9 USD
Spread / Average Target
+8.23%
Consensus